WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006091591) METHODS OF TREATING GASTROINTESTINAL INFLAMMATION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/091591    International Application No.:    PCT/US2006/006095
Publication Date: 31.08.2006 International Filing Date: 21.02.2006
IPC:
A01N 43/04 (2006.01), A61K 31/70 (2006.01)
Applicants: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA [US/US]; 1111 Franklin Street, 12th Floor, Oakland, CA 94607-5200 (US) (For All Designated States Except US).
RAZ, Eyal [IL/US]; (US) (For US Only).
KATAKURA, Kyoko; (JP) (For US Only).
LEE, Jongdae [--/US]; (US) (For US Only).
RACHMILEWITZ, Daniel [IL/IL]; (IL)
Inventors: RAZ, Eyal; (US).
KATAKURA, Kyoko; (JP).
LEE, Jongdae; (US).
RACHMILEWITZ, Daniel; (IL)
Agent: BORDEN, Paula, A.; Bozicevic, Field & Francis LLP, 1900 University Avenue, Suite 200, East Palo Alto, CA 94303 (US)
Priority Data:
60/655,455 22.02.2005 US
Title (EN) METHODS OF TREATING GASTROINTESTINAL INFLAMMATION
(FR) PROCEDES DE TRAITEMENT D'INFLAMMATION GASTRO-INTESTINALE
Abstract: front page image
(EN)The present invention provides methods of treating gastrointestinal inflammation, methods of treating inflammatory bowel disease, methods of treating Crohn's Disease, and methods of treating ulcerative colitis in an individual. The methods generally involve administering an effective amount of an agent that increases the level of a Type I interferon and/or that activates a Type I interferon signaling pathway in the individual.
(FR)L'invention se rapporte à des procédés de traitement d'inflammation gastro-intestinale, à des procédés de traitement de maladie entérique inflammatoire, à des procédés de traitement de la maladie de Crohn, ainsi qu'à des procédés de traitement de la colite ulcéreuse chez un individu. Ces procédés consistent généralement à administrer une quantité efficace d'un agent qui augmente le niveau d'un interféron de Type I et/ou active une voie de signalisation d'interféron de Type I chez l'individu.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)